EdgarLookup

Waheed Nadia

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Waheed Nadia. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

OCUL
Company Title Type Shares Price Value Date
OCUL Chief Medical Officer Award / Grant 40,363 Aug 12, 2025
OCUL Chief Medical Officer Sale 13,861 $8.05 $111,581 Jun 2, 2025
OCUL Chief Medical Officer Award / Grant 79,000 Feb 11, 2025
OCUL Chief Medical Officer Award / Grant 141,666 Jun 1, 2024